| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |